ChAdOx1 NP+M1 influenza vaccines (University of Oxford)

N/A

Report date: 2022/05/19 14:25:02

Base Information

Drug NameChAdOx1 NP+M1 influenza vaccines (University of Oxford)

Drug Alias NameChAdOx1 NP+M1

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Oxford

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oxford

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A